Testing effectiveness (Phase 2)Not Yet RecruitingNCT07293546
What this trial is testing
Phase 1/2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS)
Who this might be right for
FOXG1 Syndrome
FOXG1 Research Foundation 12
Showing 7 of 7 results